Functional significance of senescence and autophagy in cancer-associated fibroblasts from oral squamous cell carcinoma / Tan May Leng
Oral squamous cell carcinoma (OSCC) is a malignancy that arises from the epithelial cells within the oral cavity. It accounts for approximately 355,000 new cases worldwide and is exceptionally prevalent in particular geographical areas such as Papua New Guinea, the Indian subcontinent and South-E...
Saved in:
Main Author: | |
---|---|
Format: | Thesis |
Published: |
2020
|
Subjects: | |
Online Access: | http://studentsrepo.um.edu.my/11698/7/may_leng.2.pdf http://studentsrepo.um.edu.my/11698/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Malaya |
Summary: | Oral squamous cell carcinoma (OSCC) is a malignancy that arises from the epithelial
cells within the oral cavity. It accounts for approximately 355,000 new cases worldwide
and is exceptionally prevalent in particular geographical areas such as Papua New
Guinea, the Indian subcontinent and South-East Asian countries. Despite advances in
surgical management and therapeutic approaches, the five-year survival rate of OSCC
patients has not improved significantly over the past few decades. The mortality
associated with OSCC is particularly high often due to late presentation, locoregional
recurrence, distant metastases and the development of second primary tumours. A
comprehensive understanding of the molecular pathogenesis of OSCC is required to
identify new druggable targets and inform innovations in the therapeutic approach.
OSCCs are a heterogeneous group of tumours and, whilst the majority of tumours are
aggressive and genetically unstable (GU-OSCC), a subset of genetically stable cancers
(GS-OSCC) has been identified that have a more favourable prognosis. Intriguingly,
cancer-associated fibroblasts (CAFs) from these tumours are phenotypically and
functionally distinct. Many of the characteristics ascribed to CAFs are shared by
autophagic and senescent fibroblasts, suggesting that these stress responses contribute to
the tumour-promoting properties of CAFs. The present study was designed to
investigate the possible link between autophagy and senescence in CAFs from OSCCs
and normal oral fibroblasts as well as to investigate the functional significance of these
CAF phenotypes in terms of promoting tumour growth, migration and invasion. The
results showed that autophagic and senescent phenotypes were closely related and CAFs
from GU-OSCCs were shown to be more senescent and also displayed impaired
autophagic flux than normal oral fibroblasts and CAFs from GS-OSCCs. Next, the
contribution of autophagy to the activated and senescent phenotypes of oral fibroblasts
was investigated using TGF-β1 as an inducer of myofibroblast differentiation and
iv
senescence, together with inhibitors of autophagy. The results demonstrated that altered
autophagy could regulate the activated and senescent phenotypes in oral fibroblasts.
This had functional significance because conditioned media collected from oral
fibroblasts with altered autophagy significantly enhanced migration and invasion of
OSCC cells in vitro. These data indicate that the autophagy-regulated secretion by
fibroblasts might be responsible, at least in part, for modulating the malignant
phenotypes of OSCC cells. Lastly, an in vitro model to conditionally induce senescence
in normal oral fibroblasts was established. Using this model that allowed synchronous
induction of senescence in normal fibroblasts, it was demonstrated that the secretome
from senescent fibroblasts enhanced OSCC cell migration and invasion. Taken together,
the results of the present study suggest that the physiological states of CAFs within the
OSCC tumour microenvironment might reflect different stages of the same sequential
pathway and/or be part of a unified biological programme in which autophagy precedes
activation and subsequent senescence during the acquisition of pro-tumorigenic CAF
phenotypes. These physiological stages of oral CAF transdifferentiation could possibly
be targeted therapeutically in the future for the better clinical management of patients
with OSCC. |
---|